Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Savara Inc

SVRA
Current price
3.19 USD -0.09 USD (-2.74%)
Last closed 3.25 USD
ISIN US8051111016
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 653 465 920 USD
Yield for 12 month -12.84 %
1Y
3Y
5Y
10Y
15Y
SVRA
21.11.2021 - 28.11.2021

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. is headquartered in Langhorne, Pennsylvania. Address: 1717 Langhorne Newtown Road, Langhorne, PA, United States, 19047

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

10.79 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-44 262 000 USD

Last Year

-167 000 USD

Current Quarter

-69 000 USD

Last Quarter

-67 000 USD

Key Figures SVRA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -80 416 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -38.8 %
PEG Ratio
Return On Equity TTM -79.48 %
Wall Street Target Price 10.79 USD
Revenue TTM 1 000 USD
Book Value 0.74 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM -28 991 000 USD
Earnings per share -0.42 USD
Diluted Eps TTM -0.42 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics SVRA

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History SVRA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:70
Payout Ratio
Last Split Date 28.04.2017
Dividend Date 28.04.2017

Stock Valuation SVRA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 11.9082
Price Sales TTM 131146
Enterprise Value EBITDA -4.7621
Price Book MRQ 6.4235

Financials SVRA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators SVRA

For 52 weeks

3.28 USD 5.7 USD
50 Day MA 3.97 USD
Shares Short Prior Month 11 699 605
200 Day MA 4.44 USD
Short Ratio 10.97
Shares Short 12 966 906
Short Percent 9.46 %